Latest research report on “Varicella Vaccine Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5553721
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
This report contains market size and forecasts of Varicella Vaccine in global, including the following market information:
Global Varicella Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Varicella Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Varicella Vaccine companies in 2021 (%)
The global Varicella Vaccine market was valued at 4294.8 million in 2021 and is projected to reach US$ 7108.9 million by 2028, at a CAGR of 7.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella Vaccine include Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, by Type, 2021 (%)
– Injection
– Freeze-Dried Powder
Global Varicella Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, by Application, 2021 (%)
– Kids Injection
– Adults Injection
Global Varicella Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Varicella Vaccine revenues share in global market, 2021 (%)
Key companies Varicella Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Varicella Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Merck
– GSK
– Shanghai Institute
– BCHT
– Changsheng
– Keygen
– Green Cross
– Biken
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5553721
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441